Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Jeffrey R. Burton"'
Autor:
Michael E. Farkouh, Michael Domanski, George D. Dangas, Lucas C. Godoy, Michael J. Mack, Flora S. Siami, Taye H. Hamza, Binita Shah, Giulio G. Stefanini, Mandeep S. Sidhu, Jean-François Tanguay, Krishnan Ramanathan, Samin K. Sharma, John French, Whady Hueb, David J. Cohen, Valentin Fuster, Tanim N. Zazif, Hoang Thai, Jeffrey R Burton, Erick Schampaert, Jorge Escobedo, Jean-Luc Dubois-Rande, Carlos Macaya, Didier Carrie, Gert Richardt, Ariel Roguin, Chaim Lotan, Ran Kornowski, Patrizia Presbitero, J. Eduardo Sousa, Jorge G. Velásquez, Alfredo Rodriguez, Gerry Devlin, John K. French, Upendra Kaul
Publikováno v:
Journal of the American College of Cardiology. 73:629-638
Background The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for patients with diabetes mellitus (DM) and multivessel coronary disease (MVD), corona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1323aba8b8de9ca62e1b37b4a0e17cfe
https://doi.org/10.1016/j.jacc.2018.11.001
https://doi.org/10.1016/j.jacc.2018.11.001
Autor:
Michael White, Jeffrey R. Burton, Heather J. Ross, Marc Vaillancourt, R. Dorent, Jonathan G. Howlett, Haissam Haddad, Andrew Ignaszewski, Marcelo Cantarovich, Peter W. Pflugfelder
Publikováno v:
The Journal of Heart and Lung Transplantation. 27:197-202
Concentration-controlled everolimus with concomitant cyclosporine (CsA) dose reduction in renal transplantation permits preservation of kidney function without loss of efficacy. Data are lacking regarding everolimus with reduced-dose CsA in maintenan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3096aee69a5ef8d5ea741cd236672713
https://doi.org/10.1016/j.healun.2007.11.565
https://doi.org/10.1016/j.healun.2007.11.565
Autor:
G.B. John Mancini, Jeffrey R. Burton, Christopher E. Buller, Terje K. Steigen, Wayne Tymchak, David Abbott, Michael Schulzer, Cheryl Claudio
Publikováno v:
The International Journal of Cardiovascular Imaging. 24:453-462
Objectives To assess reproducibility of core laboratory performance and impact on sample size calculations. Background Little information exists about overall reproducibility of core laboratories in contradistinction to performance of individual tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8a7ca6b839affeb1b143d8db4a79ed
https://doi.org/10.1007/s10554-007-9285-x
https://doi.org/10.1007/s10554-007-9285-x
Autor:
Jeffrey R. Burton, Michael C. Tjandrawidjaja, Lee Lindholm, Paul W. Armstrong, Daniel H. Kim, Yuling Fu
Publikováno v:
Journal of Electrocardiology. 38:271-278
Background The relevance of the atrial coronary anatomy in the pathogenesis of atrial arrhythmias and atrioventricular (AV) block complicating acute myocardial infarction (AMI) remains unclear. Objectives We evaluated the location of the infarct-rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27361b604ad4125b91fa63115643f40f
https://doi.org/10.1016/j.jelectrocard.2005.01.013
https://doi.org/10.1016/j.jelectrocard.2005.01.013
Autor:
Jeffrey R. Burton, Michael Chan, Jacques Genest, Marie-Hélène Leblanc, Eduardo Azevedo, Michel White, Nadia Giannetti, Stéphane Busque, Debra Isaac, Heather J. Ross, Haissam Haddad, Jonathan G. Howlett, Peter W. Pflugfelder, Marcello Cantarovich, Andrew Ignaszewski, Ross A. Davies, Ralph Ferguson
Publikováno v:
The Journal of Heart and Lung Transplantation. 24:798-809
Background Tacrolimus improves lipid profile in renal and liver transplant recipients. The impact of conversion from cyclosporine microemulsion (Neoral) to tacrolimus (Prograf) in a large randomized study of stable heart transplant recipients with tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0417b0f773bd086b0a05343e3b7739b
https://doi.org/10.1016/j.healun.2004.05.023
https://doi.org/10.1016/j.healun.2004.05.023
Autor:
Jeffrey R. Burton, Koon K. Teo
Publikováno v:
Drugs. 62:1707-1715
During the last decade, the development of the HMG CoA reductase inhibitors, commonly referred to as 'statins', has contributed greatly to cholesterol lowering therapy and cardiovascular risk reduction. These agents are well tolerated and efficacious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad5c458d7bb8d6d4f1cd340698678da
https://doi.org/10.2165/00003495-200262120-00001
https://doi.org/10.2165/00003495-200262120-00001
Autor:
Antoine A. Bloch, Paul W. Armstrong, Jeffrey R. Burton, Donald R. Palisaitis, Christopher R. Thompson, Frans R. Van de Werf, Barry R. Rose, Desire R. Collen
Publikováno v:
American Heart Journal. 139:0820-0823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff4b17cb87adf686b789cc27f7a90e4e
https://doi.org/10.1067/mhj.2000.106608
https://doi.org/10.1067/mhj.2000.106608
Autor:
Joan E. Booth, Catherine F. Cabot, Jeffrey R. Burton, A. Michael Lincoff, Neal S. Kleiman, Shelly Sapp, Keaven M. Anderson, Eric A. Cohen, Daniel B. Mark, Eric J. Topol, Robert M. Califf, David Talley
Publikováno v:
The Lancet. 354:2019-2024
Summary Background We assessed in a randomised trial the long-term outcomes for potent adjunctive antiplatelet therapy given at the time of coronary stenting. Methods In 63 hospitals in the USA and Canada, 2399 patients were randomly assigned stentin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77930d8a46c565e8c6d2a54dd5aad3a1
https://doi.org/10.1016/s0140-6736(99)10018-7
https://doi.org/10.1016/s0140-6736(99)10018-7
Autor:
A. Michael Lincoff, Robert M. Califf, David J. Moliterno, Stephen G. Ellis, John Ducas, Jeffrey H. Kramer, Neal S. Kleiman, Eric A. Cohen, Joan E. Booth, Shelly K. Sapp, Catherine F. Cabot, James E. Tcheng, J. David Talley, Paul O. Caramori, Jeffrey R. Burton, Thomas A. Kelly, Tom B. Ivanc, Eric J. Topol
Publikováno v:
New England Journal of Medicine. 341:319-327
Background Inhibition of the platelet glycoprotein IIb/IIIa receptor with the monoclonal-antibody fragment abciximab reduces the acute ischemic complications associated with percutaneous coronary revascularization, whereas coronary-stent implantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f162fb6b07a10a5e5e994f09fc15f12c
https://doi.org/10.1056/nejm199907293410503
https://doi.org/10.1056/nejm199907293410503
Autor:
Vladimir Dzavik, Jeffrey R. Burton, Donald S. Beanlands, Dennis Humen, Terrence D. Ruddy, Danielle Leddy, Richard F. Davies, Koon K. Teo, Jean-Francois Marquis
Publikováno v:
The American Journal of Cardiology. 73:856-861
The effect of late percutaneous transluminal coronary angioplasty (PTCA) of an occluded infarct-related artery on left ventricular ejection fraction was studied in patients with a recent, first Q-wave myocardial infarction in a prospective, randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b80671e8f486303efddac08a2f81c8
https://doi.org/10.1016/0002-9149(94)90809-5
https://doi.org/10.1016/0002-9149(94)90809-5